Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | TPM2 |
| Upstream (Parents) |
|---|
| (<<) ACTN1 → TPM2 |
| (<<) ANTXR1 → TPM2 |
| (<<) ARSI → TPM2 |
| (<<) CYR61 → TPM2 |
| (<<) EFEMP2 → TPM2 |
| (<<) INHBA → TPM2 |
| (<<) MYL9 → TPM2 |
| (<<) PLAT → TPM2 |
| (<<) SCARF2 → TPM2 |
| (<<) THY1 → TPM2 |
| (<<) TIMP2 → TPM2 |
| Downstream (Children) |
|---|
| TPM2 → ACTA2 (>>) |
| TPM2 → AKT2 (>>) |
| TPM2 → ALK (>>) |
| TPM2 → ARSJ (>>) |
| TPM2 → BCAR3 (>>) |
| TPM2 → BZW2 (>>) |
| TPM2 → CDC42EP5 (>>) |
| TPM2 → CTGF (>>) |
| TPM2 → CTSF (>>) |
| TPM2 → EDNRA (>>) |
| TPM2 → ELFN1 (>>) |
| TPM2 → EMP1 (>>) |
| TPM2 → FGF1 (>>) |
| TPM2 → ITGA5 (>>) |
| TPM2 → KLK5 (>>) |
| TPM2 → KLK8 (>>) |
| TPM2 → LAMB2 (>>) |
| TPM2 → LOC399959 (>>) |
| TPM2 → MMP19 (>>) |
| TPM2 → MYLK (>>) |
| TPM2 → NNMT (>>) |
| TPM2 → NRN1 (>>) |
| TPM2 → POLR1B (>>) |
| TPM2 → PPP1R15B (>>) |
| TPM2 → PRDX6 (>>) |
| TPM2 → PRKCDBP (>>) |
| TPM2 → PTGS2 (>>) |
| TPM2 → PTRF (>>) |
| TPM2 → S100A2 (>>) |
| TPM2 → SCG5 (>>) |
| TPM2 → SEPW1 (>>) |
| TPM2 → SMTN (>>) |
| TPM2 → TWIST1 (>>) |
